Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | XENE |
---|---|---|
09:32 ET | 1233 | 43.345 |
09:34 ET | 200 | 43.22 |
09:36 ET | 100 | 43.15 |
09:38 ET | 100 | 42.95 |
09:39 ET | 204 | 42.83 |
09:41 ET | 300 | 42.955 |
09:43 ET | 100 | 42.935 |
09:45 ET | 469 | 42.955 |
09:48 ET | 689 | 42.995 |
09:50 ET | 900 | 42.925 |
09:52 ET | 3056 | 42.835 |
09:57 ET | 200 | 42.96 |
10:01 ET | 100 | 42.83 |
10:03 ET | 291 | 42.83 |
10:06 ET | 200 | 42.82 |
10:08 ET | 100 | 42.895 |
10:10 ET | 100 | 42.91 |
10:14 ET | 100 | 42.86 |
10:15 ET | 100 | 42.82 |
10:17 ET | 200 | 42.88 |
10:19 ET | 200 | 42.95 |
10:32 ET | 300 | 42.79 |
10:33 ET | 200 | 42.7625 |
10:35 ET | 100 | 42.645 |
10:39 ET | 700 | 42.78 |
10:42 ET | 100 | 42.815 |
10:44 ET | 300 | 42.74 |
10:48 ET | 100 | 42.78 |
10:50 ET | 100 | 42.815 |
10:53 ET | 100 | 42.875 |
10:55 ET | 7349 | 43.15 |
10:57 ET | 279 | 43.23 |
11:00 ET | 400 | 43.21 |
11:02 ET | 400 | 43.145 |
11:04 ET | 2908 | 43.26 |
11:06 ET | 1277 | 43.2899 |
11:08 ET | 1337 | 43.3 |
11:09 ET | 771 | 43.07 |
11:22 ET | 100 | 43.22 |
11:26 ET | 100 | 43.08 |
11:29 ET | 400 | 43.25 |
11:33 ET | 100 | 43.21 |
11:45 ET | 200 | 43.19 |
12:16 ET | 200 | 43.08 |
12:20 ET | 400 | 43.08 |
12:34 ET | 700 | 43.12 |
12:39 ET | 200 | 43.15 |
12:43 ET | 100 | 43.22 |
12:45 ET | 100 | 43.29 |
12:50 ET | 400 | 43.26 |
12:52 ET | 100 | 43.215 |
12:59 ET | 100 | 43.21 |
01:01 ET | 100 | 43.17 |
01:03 ET | 336 | 43.31 |
01:12 ET | 300 | 43.21 |
01:14 ET | 100 | 43.19 |
01:17 ET | 100 | 43.24 |
01:39 ET | 200 | 43.12 |
01:42 ET | 300 | 43.095 |
01:44 ET | 200 | 43.08 |
01:46 ET | 100 | 43.1 |
01:50 ET | 200 | 43.09 |
01:57 ET | 900 | 43.16 |
02:09 ET | 400 | 43.14 |
02:24 ET | 1000 | 43.08 |
02:31 ET | 205 | 43.13 |
02:33 ET | 400 | 43.03 |
02:38 ET | 500 | 42.965 |
02:49 ET | 100 | 42.955 |
02:51 ET | 203 | 42.99 |
02:56 ET | 600 | 43.05 |
02:58 ET | 300 | 43.08 |
03:02 ET | 100 | 43.11 |
03:03 ET | 100 | 43.145 |
03:05 ET | 200 | 43.15 |
03:07 ET | 200 | 43.16 |
03:09 ET | 100 | 43.19 |
03:12 ET | 1011 | 43.16 |
03:20 ET | 100 | 43.12 |
03:23 ET | 200 | 43.21 |
03:25 ET | 203 | 43.31 |
03:27 ET | 399 | 43.29 |
03:36 ET | 100 | 43.34 |
03:39 ET | 500 | 43.38 |
03:41 ET | 2124 | 43.31 |
03:43 ET | 100 | 43.34 |
03:45 ET | 530 | 43.37 |
03:48 ET | 364 | 43.3552 |
03:50 ET | 1820 | 43.44 |
03:52 ET | 2213 | 43.51 |
03:54 ET | 2053 | 43.57 |
03:56 ET | 4173 | 43.48 |
03:57 ET | 3755 | 43.44 |
03:59 ET | 5668 | 43.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Xenon Pharmaceuticals Inc | 3.3B | -15.9x | --- |
Janux Therapeutics Inc | 3.2B | -45.9x | --- |
Summit Therapeutics Inc | 3.1B | -3.5x | --- |
IDEAYA Biosciences Inc | 3.2B | -21.8x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Apogee Therapeutics Inc | 3.1B | -30.1x | --- |
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -15.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.